Menu Search
Equities

G3 Global Bhd

G3:KLS

G3 Global Bhd

Actions
Health CareMedical Equipment and Services
  • Price (MYR)0.03
  • Today's Change0.00 / 0.00%
  • Shares traded853.00k
  • 1 Year change+50.00%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in MYRIncome statement in MYRView more

Year on year G3 Global Bhd grew revenues 466.60% from 13.09m to 74.16m while net income improved from a loss of 8.76m to a gain of 1.89m.
Gross margin--
Net profit margin-0.50%
Operating margin-0.50%
Return on assets-0.42%
Return on equity-0.29%
Return on investment-0.69%
More ▼

Cash flow in MYRView more

In 2023, G3 Global Bhd increased its cash reserves by 13.98%, or 2.18m. Cash Flow from Financing totalled 18.82m or 25.38% of revenues. In addition the company used 17.03m for operations while cash from investing totalled 389.90k.
Cash flow per share-0.00008
Price/Cash flow per share--
Book value per share0.0163
Tangible book value per share0.0163
More ▼

Balance sheet in MYRView more

G3 Global Bhd uses little or no debt in its capital structure.
Current ratio2.10
Quick ratio2.04
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.